Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Trading Update

12 Aug 2013 07:00

RNS Number : 4221L
PROACTIS Holdings PLC
12 August 2013
 



Date:

12 August 2013

On behalf of: 

PROACTIS Holdings PLC ("Proactis" the "Company" or "the Group")

Embargoed until:

0700hrs

 

 

PROACTIS Holdings PLC

Trading Update

 

PROACTIS Holdings PLC, a global Spend Control and eProcurement solution provider, is pleased to update the market on trading for the financial year ended 31 July 2013. The Group confirms that results are expected to be in line with current market expectations, with revenues of £8.0m, adjusted EBITDA of £1.3m and adjusted profit before tax of £0.6m.

 

The Group's cash position at the end of July was approximately £2.4m and the Group remains debt free.

 

The Group starts the new financial year with an order book in excess of £6.0m and a healthy pipeline of new deal opportunities. The Board is confident of the continuing prospects for growth for the coming year.

 

The Group's results for the year ended 31 July 2013 will be announced on or around Wednesday 2 October 2013.

 

Rod Jones, Chief Executive commented:

 

"The past year has been significant for PROACTIS. With our shift toward a blended SaaS/Cloud and perpetual licensed business model just completing its third full year, we are seeing the realisation of the reliable profits that we had planned for. Our commitment to building an enhanced product remains and we are continuing to receive plaudits from the market on its breadth and depth. Our pipeline of prospects remains solid and we are confident that we will extend our already strong position within the Spend and eProcurement market place".

 

 

End

 

For further information, please contact:

 

PROACTIS Holdings PLC

Rod Jones, Chief Executive Officer

Tim Sykes, Chief Financial Office

 

Via Redleaf Polhill

 

Redleaf Polhill

Rebecca Sanders-Hewett

Jenny Bahr

0207 382 4730

finnCap Limited

Charlotte Stranner

0207 220 0500

 

 

 

 

 

 

 

 

Notes to Editors:

 

PROACTIS is a leading provider of Spend Control and eProcurement solutions. Hundreds of organisations around the world use PROACTIS software and services to streamline and automate processes and obtain best value and control in procurement.

 

Source-to-contract solutions: help organisations to automate the full buying cycle from improving the way they find, evaluate and engage suppliers to increasing "on contract" spending and enabling more effective collaboration with their trading network.

 

Purchase-to-Pay solutions: enable organisations to streamline the purchase to pay process, eliminate labour-intensive manual registration of invoices, speed up invoice matching and approvals and gain control of the "after-the-event" purchase claims.

 

Widely used in mid-to-large sized organisations across private, public and not-for-profit sectors, PROACTIS is routinely integrated with ERP and financial systems. PROACTIS also offers a range of cloud-based delivery options, including Software-as-a-Service ("SaaS") and dedicated-hosted application delivery, and flexible licensing models.

 

PROACTIS was founded in 1996 and has been listed on the London Stock Exchange since 2006 (AIM: phd). Headquartered in the UK with direct operations in Europe, North America, and Asia Pacific, PROACTIS also has an extensive global partner network.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKRNROUAWRAR
Date   Source Headline
29th Apr 20197:01 amRNSInterim Results
29th Apr 20197:00 amRNSBoard Appointment
3rd Apr 20195:17 pmRNSHolding(s) in Company
2nd Apr 20193:00 pmRNSHolding(s) in Company
1st Apr 20191:15 pmRNSHolding(s) in Company
15th Mar 201911:08 amRNSHolding(s) in Company
12th Mar 201911:14 amRNSHolding(s) in Company
8th Mar 201911:24 amRNSHolding(s) in Company
4th Mar 201911:47 amRNSHolding(s) in Company
4th Mar 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 201911:05 amRNSSecond Price Monitoring Extn
1st Mar 201911:00 amRNSPrice Monitoring Extension
1st Mar 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSDirector/PDMR Shareholding
28th Feb 20192:05 pmRNSSecond Price Monitoring Extn
28th Feb 20192:00 pmRNSPrice Monitoring Extension
28th Feb 20197:00 amRNSTrading Update and Notice of Results
31st Jan 20199:33 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSConversion of Convertible Loan Note & TVR
10th Jan 20197:00 amRNSDirectorate Changes and Trading Update
19th Dec 20183:23 pmRNSResult of AGM
14th Dec 20187:00 amRNSIssue of Equity
28th Nov 20187:00 amRNSAnnual Report and Accounts & Notice of AGM
30th Oct 20187:01 amRNSFinal Results
30th Oct 20187:00 amRNSDirector Appointment
28th Sep 20187:00 amRNSDirector/PDMR Shareholding
24th Sep 20188:21 amRNSNotice to Convert Acquisition Loan Notes
22nd Aug 20187:00 amRNSTrading Update and Notice of Results
14th Aug 201810:09 amRNSHolding(s) in Company
7th Aug 20187:00 amRNSTrading Update & Acquisition of Esize Holdings BV
3rd Aug 20181:34 pmRNSHolding(s) in Company
24th Jul 201810:32 amRNSHolding(s) in Company
24th Jul 20187:00 amRNSHolding(s) in Company
18th Jun 20187:00 amRNSProactis launches new brand identity
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
24th May 20189:53 amRNSHolding(s) in Company
24th May 20189:52 amRNSHolding(s) in Company
18th May 201811:49 amRNSHolding(s) in Company
14th May 20185:05 pmRNSHolding(s) in Company
24th Apr 20182:05 pmRNSSecond Price Monitoring Extn
24th Apr 20182:00 pmRNSPrice Monitoring Extension
24th Apr 201811:06 amRNSSecond Price Monitoring Extn
24th Apr 201811:00 amRNSPrice Monitoring Extension
24th Apr 20187:00 amRNSInterim Results
22nd Mar 20187:00 amRNSIssue of Equity
14th Mar 20187:00 amRNSDirector/PDMR Shareholdings
13th Mar 20187:00 amRNSResult of Hubwoo Tender Offer
19th Feb 20187:00 amRNSIssue of Equity
12th Feb 20187:00 amRNSTrading Update and Notice of Results
6th Feb 20187:00 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.